-
Mashup Score: 17Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO Registry - 3 month(s) ago
Little is known about the bleeding risk associated with cangrelor use in patients with myocardial infarction (MI) who are exposed to an oral P2Y12 inhibitor before coronary angiography.
Source: www.jscai.orgCategories: General Medicine News, CardiologistsTweet
Risk of Bleeding Among Cangrelor-Treated Patients Administered Upstream P2Y12 Inhibitor Therapy: The CAMEO Registry - Journal of the Society for Cardiovascular Angiography & Interventions https://t.co/zaC110pQAA #cardiology #cardiovascular #bleeding #cardiotwitter @MyJSCAI